sequenc
bacteri
pneumonia
ard
follow
accur
person
cap
estenssoro
et
al
observ
patient
admit
intens
care
unit
studi
period
patient
mechan
ventil
met
criteria
ard
total
number
patient
ventil
patient
predomin
etiolog
ard
sepsi
pneumonia
frequent
singl
entiti
case
author
differenti
cap
nosocomi
pneumonia
followedup
patient
pneumonia
develop
ard
identifi
risk
factor
figur
given
group
compar
previou
studi
use
similar
ard
criteria
pneumonia
remain
frequent
singl
caus
sepsi
howev
draw
meaning
conclus
need
larger
prospect
cohort
studi
observ
patient
cap
progress
ard
identifi
reason
sever
cap
progress
ard
import
first
discov
sever
cap
progress
sepsi
prospect
cohort
studi
patient
cap
includ
subject
identifi
met
criteria
septic
shock
multivari
analysi
incorpor
age
sex
presenc
chronic
pulmonari
cardiac
renal
hepat
neurolog
diseas
alcohol
consumpt
prior
antibiot
exposur
delay
antibiot
therapi
genotyp
factor
remain
signific
predictor
septic
shock
genotyp
increas
age
studi
design
repeat
focu
possibl
role
intracellular
adhes
molecul
type
fail
yield
signific
associ
cap
sepsi
ten
patient
cohort
ard
note
whether
sepsi
septic
shock
preced
ard
data
howev
directli
address
issu
whether
sepsi
requir
link
ard
pneumonia
thu
risk
factor
develop
sever
sepsi
ard
cours
cap
remain
undefin
issu
assess
impact
pneumonia
natur
cours
ard
obscur
uncertainti
diagnos
nosocomi
pneumonia
approach
construct
firm
diagnost
criteria
vap
inher
limit
particular
even
reliabl
measur
diagnos
vap
use
quantit
cultur
bronchoscop
retriev
respiratori
sampl
protect
specimen
brush
andor
bronchoalveolar
lavag
preclud
falseneg
falseposit
result
rang
accordingli
incid
pneumonia
cours
ard
report
variou
studi
vari
larg
issu
review
detail
iregui
kollef
delclaux
et
al
perform
prospect
studi
lower
respiratori
tract
colon
infect
patient
sever
ard
repeat
quantit
cultur
plug
telescop
cathet
specimen
everi
h
develop
ard
use
clinic
microbiolog
criteria
investig
found
incid
vap
episod
per
ventilatorday
previou
lower
respiratori
tract
colon
similar
microorgan
preced
develop
vap
almost
case
line
data
markowicz
et
al
found
incid
vap
among
patient
ard
incid
earlyonset
pneumonia
day
incid
lateonset
vap
report
high
meduri
et
al
found
patient
ard
studi
vap
use
bilater
bronchoalveolar
lavag
similarli
chastr
et
al
obtain
sampl
lower
airway
use
bronchoalveolar
lavag
protect
specimen
brush
critic
ill
patient
clinic
evid
vap
occurr
vap
significantli
higher
among
patient
ard
among
patient
without
ard
data
suggest
ard
may
risk
factor
predispos
ill
person
vap
suggest
investig
howev
prolong
durat
mechan
ventil
patient
ard
may
import
predispos
vap
ard
investig
cohort
patient
fulfil
ard
criteria
diagnost
tool
nosocomi
pneumonia
within
first
h
diagnosi
overal
patient
clinic
suspect
nosocomi
pneumonia
first
day
receiv
diagnosi
ard
infect
could
microbiolog
confirm
thu
microbiolog
confirm
pneumonia
rate
within
h
patient
first
diagnosi
ard
patient
microbiolog
confirm
nosocomi
pneumonia
admit
hospit
least
day
receiv
diagnosi
rang
day
mechan
ventil
h
help
inform
regard
differenti
etiolog
bilater
pulmonari
infiltr
ard
vs
pneumonia
may
come
interpret
trigger
receptor
express
myeloid
cell
investig
use
solubl
trigger
receptor
express
myeloid
cell
sampl
bronchoalveolar
lavag
fluid
marker
pneumonia
patient
receiv
mechan
ventil
mechan
ventil
patient
vap
detect
solubl
trigger
receptor
express
myeloid
cell
type
much
accur
diagnost
tool
clinic
find
strongest
independ
factor
predict
pneumonia
accord
logist
regress
analysi
sensit
specif
control
group
includ
larg
number
patient
ard
patient
differenti
power
solubl
trigger
receptor
express
myeloid
cell
test
specif
hypothesi
howev
solubl
trigger
receptor
express
myeloid
cell
shown
elev
newli
admit
critic
ill
patient
suspect
sepsi
exclud
larg
patient
group
extrapulmonari
pathogenesi
ard
caus
sepsi
studi
role
specif
pathogen
induc
ard
complex
known
risk
factor
ard
eg
sepsi
shock
trauma
andor
gastric
aspir
would
balanc
relev
data
mainli
deriv
small
case
seri
case
report
investig
may
bias
toward
report
moresever
case
leav
milder
case
unrecogn
reason
tabl
may
repres
spectrum
moresever
ill
caus
known
bacteri
viral
parasit
infect
preced
pneumonia
pulmonari
involv
literatur
obvious
bias
toward
case
report
seem
restrict
group
bacteria
previous
refer
atyp
like
case
known
risk
etiolog
sever
pneumonia
streptococcu
pneumonia
andor
pseudomona
aeruginosa
infect
sequenc
pneumonia
sepsi
ard
quit
obviou
consid
noteworthi
markowicz
et
al
compar
patient
ard
patient
without
ard
found
nonfer
gramneg
bacteria
caus
significantli
case
pneumonia
among
patient
ard
mortal
rate
compar
group
incid
pneumonia
increas
time
mechan
ventil
case
pneumonia
due
p
aeruginosa
specif
cytotox
mediat
may
explain
high
rate
lung
injuri
infect
definit
diagnos
infect
mycoplasma
chlamydia
legionella
speci
requir
effort
infect
may
undiscov
time
enhanc
sever
probabl
sepsi
andor
ard
except
patient
receiv
initi
empir
antimicrobi
treatment
consid
fulli
ineffect
pathogen
routin
investig
fail
identifi
pathogen
etiolog
suspect
proven
later
cours
diseas
therefor
avail
data
interpret
evid
specif
role
pathogen
induc
lung
injuri
tuberculosi
common
primari
caus
respiratori
failur
requir
mechan
ventil
therefor
also
instantli
associ
ard
agarw
et
al
review
patient
ard
found
sever
pneumonia
sepsi
relev
underli
ill
provid
inform
patient
ard
tuberculosi
patient
mechan
ventil
ziehlneelsen
stain
reveal
acidfast
bacilli
patient
fiberopt
bronchoscopi
transbronchi
lung
biopsi
perform
patient
histopatholog
examin
use
patient
mortal
rate
patient
remark
low
compar
previou
report
patient
pulmonari
tuberculosi
requir
mechan
ventil
patient
patient
miliari
tuberculosi
ard
patient
sharma
et
al
found
prolong
durat
ill
miliari
tuberculosi
absolut
lymphocytopenia
elev
liver
enzym
level
independ
predictor
develop
ard
howev
review
cohort
patient
report
patient
ard
confirm
low
preval
sever
lung
injuri
patient
tuberculosi
proport
viral
etiolog
cap
recent
investig
among
hospit
patient
preval
viral
pneumonia
person
preval
mix
viral
andor
bacteri
pneumonia
person
influenza
far
common
viral
etiolog
annual
preval
show
season
pattern
seem
person
mix
infect
increas
risk
progress
sepsi
septic
shock
howev
data
ard
provid
studi
also
observ
studi
rabagliati
et
al
provid
inform
cohort
hospit
patient
influenza
state
patient
pneumonia
patient
die
surprisingli
addit
inform
observ
trial
regard
issu
influenza
ard
immunocompet
host
avail
howev
may
assum
progress
influenza
infect
sever
cap
sepsi
andor
septic
shock
ard
rare
event
contrast
current
evalu
human
case
avian
influenza
viru
infect
clinic
descript
case
infect
vietnam
ard
explicitli
mention
sever
respiratori
failur
present
case
bilater
pulmonari
infiltr
occur
mortal
indic
criteria
ard
may
fulfil
high
percentag
patient
least
descript
inform
regard
preval
ard
among
human
infect
deriv
thai
pediatr
case
seri
pulmonari
infiltr
observ
children
occasion
progress
subsequ
deterior
final
common
pattern
acut
respiratori
distress
syndrom
p
almost
patient
ard
die
paramount
interest
virtual
confirm
case
remain
unpublish
therefor
must
assum
progress
ard
common
among
human
avian
influenza
viru
infect
clinic
pictur
infect
recent
review
report
averag
level
plasma
among
patient
avian
influenza
die
time
high
among
healthi
control
specul
respons
may
respons
part
sepsi
syndrom
ard
multiorgan
failur
observ
mani
patient
infect
studi
infect
due
coronaviru
sever
acut
respiratori
syndrom
sar
improv
understand
viral
infect
sever
respiratori
diseas
wherea
sar
qualit
term
defin
sever
lung
injuri
ard
quantit
term
henc
coronaviru
infect
provok
sar
sever
enough
call
ard
sar
alway
character
coronaviru
infect
consequ
chen
et
al
identifi
ard
patient
sar
describ
age
year
diabet
mellitu
lactat
dehydrogenas
independ
predictor
ard
overal
mortal
patient
patient
develop
ard
peiri
et
al
found
lower
figur
patient
progress
ard
followup
period
also
identifi
age
chronic
hepat
b
viru
infect
treat
lamuvidin
signific
risk
factor
mention
ldh
mortal
report
studi
surprisingli
low
patient
subtract
patient
die
myocardi
infarct
patient
die
sepsi
ard
report
sever
seri
suggest
substanti
number
patient
develop
respiratori
failur
ard
patient
requir
admiss
intens
care
unit
mortal
varicella
infect
chickenpox
common
contagi
infect
caus
varicellazost
viru
benign
outcom
children
pneumonia
frequent
complic
varicella
infect
healthi
adult
lead
caus
death
among
vaccineprevent
diseas
case
report
describ
young
male
bilater
infiltr
rapid
progress
ard
antiinfect
treatment
invari
contain
acyclovir
case
treatment
contain
corticosteroid
andor
immunoglobulin
one
review
found
patient
lifethreaten
varicella
pneumonia
treat
corticosteroid
patient
significantli
shorter
hospit
intens
care
unit
stay
day
respect
patient
die
newer
case
seri
patient
sever
varicella
pneumonia
establish
diagnosi
ard
patient
patient
die
patient
seri
previou
contact
varicellainfect
patient
varicella
infect
childhood
varicella
infect
go
along
characterist
rash
therefor
diagnosi
treatment
almost
alway
establish
immedi
bilater
infiltr
seem
common
parasit
infect
pulmonari
involv
immunocompet
patient
may
regard
rare
diseas
depend
geograph
locat
consid
regularli
acut
eosinophil
pneumonia
list
pathogen
deriv
literatur
malaria
due
infect
plasmodium
falciparum
howev
note
remark
often
literatur
associ
ard
losert
et
al
review
patient
admit
hospit
malaria
p
falciparum
infect
admit
intens
care
unit
four
patient
underw
intub
mechan
ventil
develop
ard
patient
die
anoth
studi
intens
care
unit
patient
consid
develop
ard
mortal
complic
malaria
coma
sepsi
shock
preval
among
group
patient
acut
lung
injuri
studi
retrospect
report
bruneel
et
al
therefor
would
like
support
hypothesi
ard
associ
multiorgan
failur
complic
cours
sever
infect
p
falciparum
mechan
seem
independ
caus
agent
date
sepsi
seem
princip
link
pneumonia
ard
howev
prospect
observ
data
suppos
sequenc
avail
preval
pneumonia
cours
ard
seem
particularli
high
whether
patient
ard
suscept
pneumonia
simpli
risk
factor
remain
unknown
limit
methodolog
diagnosi
vap
ard
recent
research
suggest
host
factor
major
bear
develop
ard
accordingli
individu
role
specif
pathogen
develop
ard
difficult
assess
recent
new
respiratori
virus
receiv
particular
attent
review
suggest
infect
coronaviru
avian
influenza
viru
associ
except
high
incid
lung
injuri
ard
